Figure 5.
A detailed evaluation of the concentrations of individual species of monohexosylceramides (Hex 1 Cer, 22 species) in patients with MCI compared to the NC group of T2DM patients (A). This analysis identified significantly higher levels of Hex1Cer (d16:0_22:6) in patients with MCI compared to the NC group of T2DM patients [*p < 0.05, (A, B)]. Although variations were observed among several other Hex1Cer species, no significant differences were observed between the two groups.